News file for: Vaccine

Researchers Engineer Potent Antibody Against Dengue Virus

Researchers Engineer Potent Antibody Against Dengue Virus

Researchers from Singapore and the U.S. have engineered a potent antibody against the dengue virus.

WHO: Everything You Need To Know About The H7N9 Influenza Virus

WHO: Everything You Need To Know About The H7N9 Influenza Virus

The World Health Organization has released a FAQ list answering some questions relating to the H7N9 influenza A virus outbreak in China.

Sanofi Pasteur, Xiamen University To Develop Universal Flu Vaccine

Sanofi Pasteur, Xiamen University To Develop Universal Flu Vaccine

Sanofi Pasteur and Xiamen University in China have agreed to jointly develop a universal flu vaccine.

Study’s Asian Dengue Estimates Are Too Low, Says Expert

Study’s Asian Dengue Estimates Are Too Low, Says Expert

An expert says that fresh estimates of the number of cases of dengue fever in South-East Asia and one country in South Asia are too low.

Takeda Submits NDA Application For Cell Culture-Based H5N1 Vaccines

Takeda Submits NDA Application For Cell Culture-Based H5N1 Vaccines

Takeda Pharma has submitted New Drug Applications for cell culture-based H5N1 influenza vaccines to the Ministry of Health, Labor and Welfare in Japan.

Sinovac Reports PhIII Trial Results For HFMD Vaccine Candidate

Sinovac Reports PhIII Trial Results For HFMD Vaccine Candidate

Chinese vaccine provider Sinovac Biotech Ltd. has completed a Phase III clinical trial on its Enterovirus 71 vaccine against hand, foot, and mouth disease.

Inviragen Advances Dengue Vaccine Into Second Stage Of Phase II Study

Inviragen Advances Dengue Vaccine Into Second Stage Of Phase II Study

Inviragen, Inc. has initiated the second stage of an ongoing Phase II study of DENVax™, its investigational dengue vaccine.

Flu Vaccine Candidate May Have Broad Spectrum Efficacy

Flu Vaccine Candidate May Have Broad Spectrum Efficacy

Researchers have designed a new drug to safeguard against epidemic and pandemic influenza virus strains.

Vabiotech Licenses Japanese Encephalitis Technology From Inviragen

Vabiotech Licenses Japanese Encephalitis Technology From Inviragen

Vietnam’s VABIOTECH has acquired rights to Inviragen’s proprietary Japanese encephalitis technology to produce a cell-derived vaccine.

Microneedles Send Tiny Doses Of Vaccine To The Skin

Microneedles Send Tiny Doses Of Vaccine To The Skin

An Australian biomedical engineer, Mark Kendall, has won the 2012 Rolex Awards for changing the way life-saving vaccines are delivered.